Ubs Group Ag Yumanity Therapeutics, Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$1.02 - $1.99 $11,708 - $22,843	11,479 New	11,479 $21,000
Q1 2022 May 16, 2022	SELL	$0.97 - $3.27 $715 - $2,413	-738 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.81 - $10.48 $1,191 - $4,443	-424 Reduced 36.49%	738 $2,000
Q3 2021 Nov 15, 2021	SELL	$8.3 - $12.04 $9,096 - $13,195	-1,096 Reduced 48.54%	1,162 $12,000
Q2 2021 Aug 13, 2021	BUY	$11.27 - $19.64 $22,179 - $38,651	1,968 Added 678.62%	2,258 $26,000
Q1 2021 May 12, 2021	BUY	$16.69 - $22.52 $4,840 - $6,530	290 New	290 $5,000

Ticker YMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,856,500
Description
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.